Nalazite se na CroRIS probnoj okolini. Ovdje evidentirani podaci neće biti pohranjeni u Informacijskom sustavu znanosti RH. Ako je ovo greška, CroRIS produkcijskoj okolini moguće je pristupi putem poveznice www.croris.hr
izvor podataka: crosbi

Olanzapine use in a patient with schizophrenia and the risk of diabetes : case report (CROSBI ID 162963)

Prilog u časopisu | stručni rad | međunarodna recenzija

Folnegović-Šmalc, Vera ; Jukić, Vlado ; Kozumplik, Oliver ; Mimica, Ninoslav ; Uzun, Suzana Olanzapine use in a patient with schizophrenia and the risk of diabetes : case report // European psychiatry, 19 (2004), 1; 62-64. doi: 10.1016/j.eurpsy.2003.09.003

Podaci o odgovornosti

Folnegović-Šmalc, Vera ; Jukić, Vlado ; Kozumplik, Oliver ; Mimica, Ninoslav ; Uzun, Suzana

engleski

Olanzapine use in a patient with schizophrenia and the risk of diabetes : case report

Based on this experience, we find that glucose monitoring should be considered during treatment with olanzapine. In order to evaluate frequency of hyperglycemia, the probability of glucose elevation during olanzapine therapy, as well as the connection of hyperglycemia with olanzapine therapy, further clinical investigations are necessary.

olanzapine ; patient ; schizophrenia ; diabetes

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

Podaci o izdanju

19 (1)

2004.

62-64

objavljeno

0924-9338

10.1016/j.eurpsy.2003.09.003

Povezanost rada

Kliničke medicinske znanosti

Poveznice
Indeksiranost